01 1Olon S.p.A
01 1RIFAMPICIN
01 1Italy
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-05-13
Pay. Date : 2022-03-29
DMF Number : 36879
Submission : 2022-04-04
Status : Active
Type : II
20
Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RIFAMPICIN, with a corresponding US DMF Number 36879.
Remarkably, this DMF maintains an Active status since its submission on April 04, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 13, 2022, and payment made on March 29, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
